BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.8 CNY | +0.41% |
|
+14.75% | -9.43% |
| 05/03 | Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection | MT |
| 23/01 | Aosaikang Pharmaceutical Registers Breast Cancer Drug | MT |
| Sales 2021 | 3.11B 429M 35.75B | Sales 2022 | 1.87B 258M 21.55B | Capitalization | 7.37B 1.02B 84.8B |
|---|---|---|---|---|---|
| Net income 2021 | 380M 52.44M 4.37B | Net income 2022 | -226M -31.19M -2.6B | EV / Sales 2021 | 3.26 x |
| Net cash position 2021 | 1.67B 231M 19.26B | Net cash position 2022 | 1.55B 215M 17.89B | EV / Sales 2022 | 3.11 x |
| P/E ratio 2021 |
31
x | P/E ratio 2022 |
-33.1
x | Employees | 1,215 |
| Yield 2021 |
0.79% | Yield 2022 |
-
| Free-Float | 18.22% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.41% | ||
| 1 week | +14.75% | ||
| Current month | -7.28% | ||
| 1 month | +2.94% | ||
| 3 months | -1.90% | ||
| 6 months | +11.49% | ||
| Current year | -9.43% |
1 week
8.40
9.90
1 month
8.3310.65
Current year
6.5011.34
1 year
6.5012.28
3 years
6.5014.90
5 years
6.5022.28
10 years
6.5022.28
| Managers | Title | Age | Since |
|---|---|---|---|
Jing Fei Ma
CEO | Chief Executive Officer | 36 | 30/19/30 |
Tao Han
DFI | Director of Finance/CFO | 42 | 18/19/18 |
You Yin Xu
BRD | Director/Board Member | 56 | 18/19/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Wen Liu
BRD | Director/Board Member | 65 | 18/19/18 |
Qing Chen
CHM | Chairman | 65 | 18/19/18 |
You Yin Xu
BRD | Director/Board Member | 56 | 18/19/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 9.8 | +0.41% | 5,313,910 |
| 25/24/25 | 9.76 | +3.06% | 4,616,010 |
| 24/24/24 | 9.47 | -1.25% | 7,732,200 |
| 23/24/23 | 9.59 | +9.98% | 6,253,600 |
| 22/24/22 | 8.72 | +2.11% | 4,787,309 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD., formerly Beijing New Oriental Star Petrochemical Engineering Co., Ltd., is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company produces proton pump inhibitor injections through its subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Sector
Pharmaceuticals
Calendar
29/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.43% | 1.26B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002755 Stock
